Skip to main content

Advertisement

Table 4 Agreements among seven classifiers discriminating an individual, evaluated using the fivefold cross validation technique

From: Statistical prediction of immunity to placental malaria based on multi-assay antibody data for malarial antigens

  LR-Full LR-Reduced RPART RF LDA QDA SVM
LR-Full
 (a) 1.00 0.85 0.76 0.73 0.53 0.51 0.71
 (b) 1.00 0.87 0.79 0.77 0.52 0.51 0.74
 (c) 1.00 0.77 0.66 0.63 0.58 0.53 0.62
LR-Reduced
 (a) 0.85 1.00 0.76 0.72 0.57 0.53 0.73
 (b) 0.87 1.00 0.79 0.77 0.53 0.52 0.75
 (c) 0.77 1.00 0.67 0.58 0.70 0.58 0.65
RPART
 (a) 0.76 0.76 1.00 0.86 0.49 0.50 0.76
 (b) 0.79 0.79 1.00 0.89 0.48 0.49 0.80
 (c) 0.66 0.67 1.00 0.77 0.54 0.51 0.64
RF
 (a) 0.73 0.72 0.86 1.00 0.42 0.47 0.76
 (b) 0.77 0.77 0.89 1.00 0.41 0.47 0.80
 (c) 0.63 0.58 0.77 1.00 0.44 0.47 0.64
LDA
 (a) 0.53 0.57 0.49 0.42 1.00 0.82 0.54
 (b) 0.52 0.53 0.48 0.41 1.00 0.84 0.52
 (c) 0.58 0.70 0.54 0.44 1.00 0.74 0.61
QDA
 (a) 0.51 0.53 0.50 0.47 0.82 1.00 0.52
 (b) 0.51 0.52 0.49 0.47 0.84 1.00 0.51
 (c) 0.53 0.58 0.51 0.47 0.74 1.00 0.55
SVM
 (a) 0.71 0.73 0.76 0.76 0.54 0.52 1.00
 (b) 0.74 0.75 0.80 0.80 0.52 0.51 1.00
 (c) 0.62 0.65 0.64 0.64 0.61 0.55 1.00
  1. Based on (a). overall classification, (b). PM− classification, and (c). PM+ classification